Reported results
- Revenue from continuing operations was $55.4 million for the fourth fiscal quarter of 2026.
- Annualized Recurring Revenue (ARR) from continuing operations was $177.0 million for the fourth fiscal quarter of 2026.
- Net loss from continuing operations was $5.1 million for the fourth fiscal quarter of 2026.
- Adjusted EBITDA from continuing operations (non-GAAP) was $15.2 million for the fourth fiscal quarter of 2026.
- Adjusted diluted earnings per share from continuing operations (non-GAAP) was $0.30 for the fourth fiscal quarter of 2026.
- Adjusted EBITDA from continuing operations (non-GAAP) was $58.7 million for the full fiscal year 2026.
Guidance
- Fiscal year ending September 30, 2027 revenue: $220,000 - $235,000 (in thousands)
- Fiscal year ending September 30, 2027 Adjusted EBITDA (non-GAAP): $61,250 - $68,750 (in thousands)
- Fiscal year ending September 30, 2027 Depreciation and internally developed software amortization: $10,000 - $12,000 (in thousands)
- Fiscal year ending September 30, 2027 Cash interest expense: $6,000 - $8,000 (in thousands)
- Fiscal year ending September 30, 2027 Adjusted diluted earnings per share (non-GAAP): $1.23 - $1.41
Notes
Historical results of the Merchant Services Business and Healthcare RCM Business have been reflected in discontinued operations, and prior period results have been recast to reflect this presentation.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-17 (8-K, Item 2.02). Read the original filing on sec.gov.
